A Multicenter, Open Label, Phase I/Randomized II Study to Evaluate Safety, Pharmacokinetics and Efficacy of BIBF 1120 in Comparison With Sorafenib for Advanced Hepatocellular Carcinoma Patients in Asia.
收藏DataCite Commons2025-06-01 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00003581/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
This study is to evaluate the safety, appropriate dose, and efficacy of BIBF 1120 in liver cancer patients
提供机构：
Vivli
创建时间：
2019-04-12
